Key result
Diabetes downregulates Rapgef5 and upregulates Ing1 in STEMI, potentially exacerbating post-MI remodeling.
Why the study?
Diabetes mellitus is a major risk factor for MI, but the molecular mechanisms exacerbating post-MI cardiac remodeling remain unclear.
Diabetes aggravates post-MI cardiac remodeling via Rapgef5/Ing1-mediated apoptosis and proliferation, highlighting novel therapeutic targets.
Answers are grounded in this paper and cite their sources.
Does not alter diabetic STEMI management; leaves open Rapgef5/Ing1 as targets pending human validation.
Introduction: Diabetes mellitus is a major risk factor for myocardial infarction (MI), yet its molecular mechanisms exacerbating post-MI cardiac remodeling remain unclear. Methods: Type 2 diabetes mellitus mouse model was developed through a high-sugar and high-fat diet (HFD), followed by MI surgery. Four weeks post-surgery, cardiac function was evaluated via echocardiography, and cardiac pathology was examined using Masson's trichrome and wheat germ agglutinin staining. High-throughput sequencing identified differentially expressed mRNAs and long non-coding RNAs (LncRNAs) in diabetic mice with MI. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses, along with LncRNA-target-gene analysis, were performed. Validation in human samples of diabetic patients with STEMI confirmed the influence of HFD on the expression of specific genes. Results: The results demonstrate that diabetes significantly impairs cardiac function, exacerbates cardiac fibrosis and hypertrophy. In addition, our extensive examination of human samples has conclusively demonstrated that diabetes significantly modulates the expression of genes (Rapgef5 and Ing1) within the cardiac tissue of individuals afflicted with STEMI, underscoring the intricate interplay between these conditions. In addition, we have found that Rapgef5 and Ing1 are involved in diabetes-mediated cardiomyocyte apoptosis and proliferation following myocardial infarction. Discussion: Diabetes aggravates post-MI remodeling via Rapgef5/Ing1-mediated apoptosis and proliferation, these findings highlight novel therapeutic targets for diabetic cardiovascular complications.
No takes yet. Share an insight, caveat, or question.
Duan et al. (2025) studied ST-elevation myocardial infarction (STEMI) with or without diabetes (n=10). Diabetes vs. Without diabetes was evaluated on Cardiac tissue expression of Rapgef5 and Ing1. Diabetes significantly downregulated Rapgef5 and upregulated Ing1 expression in the cardiac tissue of patients with STEMI, which may exacerbate post-myocardial infarction remodeling.
Synapse has enriched 10 related papers. Consider them for comparative context: